A key role of dentric cells in probiotic functionality

PLoS ONE

Volumn 2, Issue 3, 2007, Pages

  Foligne, Benoit ^a,b   Zoumpopoulou, Georgia ^a   Dewulf, Joelle ^a   Younes, Amena Ben ^a   Chareyre, Fabrice ^b   Strard, Jean Claude ^b   Pot, Bruno ^a   Grangette, Corinne ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; LACTIC ACID; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CELL THERAPY; CELL TRANSFER; COLITIS; CONTROLLED STUDY; DENDRITIC CELL; ENTERITIS; GENE EXPRESSION; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS; MOUSE; NONHUMAN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; HUMAN; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; LACTOBACILLUS RHAMNOSUS; MICROBIOLOGY; PHAGOCYTOSIS; PHYSIOLOGY; STREPTOCOCCUS GORDONII;

ANIMALS; COLITIS; DENDRITIC CELLS; HUMANS; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; LACTOBACILLUS RHAMNOSUS; MICE; PHAGOCYTOSIS; PROBIOTICS; STREPTOCOCCUS GORDONII;

EID: 34347271190     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000313     Document Type: Article

References (54)

1. Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21: 685-711.
2. Sakaguchi S (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101: 455-458.
3. Duchmann R, Schmitt E, Knolle P, Meyer zum Buschenfelde KH, Neurath M (1996) Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 26: 934-938.
4. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
5. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, et al. (2000) Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289: 1560-1563.
6. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, et al. (2004) Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 5: 104-112.
7. Madsen KL, Doyle JS, Jewell D, Tavernini MM, Fedorak N (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116: 1107-1114.
8. Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633.
9. Lammers KM, Vergopoulos A, Babel N, Gionchetti P, Rizzello F, et al. (2005) Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflamm Bowel Dis 11: 447-454.
10. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, et al. (2005) VSL3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100: 1539-1546.
11. Christensen HR, Frokiaer H, Pestka JJ (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 68: 171-178.
12. Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, et al. (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53: 1602-1609.
13. Foligne B, Nutten S, Grangette C, Dennin V, Goudercourt D, et al. (2007) World J Gastroenterol 13: 242-249.
14. Sheil B, McCarthy JO, Mahony L, Bennett MW, Ryan P, et al. (2004) Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 53: 694-700.
15. Foligne B, Grangette C, Pot B (2005) Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects. Gut 54: 727-728.
16. Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, et al. (2005) Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 115: 1260-1267.
17. Tan PH, Sagoo P, Chan C, Yates JB, Campbell J, et al. (2005) Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol 174: 7633-7644.
18. Zhu M, Wei MF, Liu F, Shi HF, Wang G (2003) Interleukin-10 modified dendritic cells induce allo-hyporesponsiveness and prolong small intestine allograft survival. World J Gastroenterol 9: 2509-2512.
19. Grohmann U, Fallarino F, Puccetti P (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 24: 242-248.
20. Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762-774.
21. Wolf AM, Wolf D, Rumpold H, Moschen AR, Kaser A, et al. (2004) Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol 113: 47-55.
22. Corinti S, Medaglini D, Cavani A, Rescigno M, Pozzi G, et al. (1999) Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes. J Immunol 163: 3029-3036.
23. Oldenhove G, de Heusch M, Urbain-Vansanten G, Urbain J, Maliszewski C, et al. (2003) CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J Exp Med 198: 259-266.
24. Zelenay S, Demengeot J (2006) Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells". J Immunol 177: 2036-2037; author reply 2037-8.
25. Stephens LA, Anderton SM (2006) Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells". J Immunol 177: 2036; author reply 2037-8.
26. Kaisho T, Akira S (2001) Dendritic-cell function in Toll-like receptor-and MyD88-knockout mice. Trends Immunol 2: 8-83.
27. Elson CO, Beagley KW, Sharmanov AT, Fujihashi K, Kiyono H, et al. (1996) Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol 157: 2174-2185.
28. Mottet C, Uhlig HH, Powrie F (2003) Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170: 3939-3943.
29. Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, et al. (2005) Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A 102: 10321-10326.
30. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol 174: 3237-46.
31. Braat H, van den Brande J, van Tol E, Hommes D, Peppelenbosch M, et al. (2004) Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am J Clin Nutr 80: 1618-1625.
32. Te Velde AA, Verstege MI, Hommes DW (2006) Critical appraisal of the Current Practice in Murine TNBS-induced Colitis. Inflamm Bowel Dis 12: 995-999.
33. Vandenbroucke K, Hans W, Van Huysse J, Neirynck S, Demetter P, et al. (2004) Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 127: 502-513.
34. Nishihara T, Matsuda M, Araki H, Oshima K, Kihara S, et al. (2006) Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 131: 853-861.
35. Hollenbach E, Vieth M, Roessner A, Neumann M, Malfertheiner P, et al. (2005) Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. J Biol Chem 280: 14981-14988.
36. McKenzie BS, Kastelein RA, Cua DJ (2006) Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27: 17-23.
37. Fiorucci S, Wallace JL, Mencarelli A, Distrutti E, Rizzo G, et al. (2004) A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proc Natl Acad Sci U S A 101: 15736-15741.
38. Cong Y, Konrad A, Iqbal N, Hatton RD, Weaver CT, et al. (2005) Generation of antigen-specific, Foxp3-expressing CD4+ regulatory T cells by inhibition of APC proteosome function. J Immunol 174: 2787-2795.
39. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, et al. (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520-528.
40. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
41. Torok HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, et al. (2004) Crohn's disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology. 127: 365-366.
42. Watanabe T, Kitani A, Murray PJ, Strober W (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 5: 800-808.
43. van Heel DA, Ghosh S, Hunt KA, Mathew CG, Forbes A, et al. (2005) Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut 54: 1553-1557.
44. Travassos LH, Girardin SE, Philpott DJ, Blanot D, Nahori M, et al. (2004) Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 5: 1000-1006.
45. Hackstein H, Thomson AW (2004) Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4: 24-34.
46. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92.
47. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443-451.
48. Noel C, Gerbod D, Delgado-Viscogliosi P, Fast NM, Younes AB, et al. (2003) Morphogenesis during division and griseofulvin-induced changes of the microtubular cytoskeleton in the parasitic protist, Trichomonas vaginalis. Parasitol Res 89: 487-494.
49. Foligne B, Nutten S, Steidler L, Dennin V, Goudercourt D, et al. (2006) Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects. Dig. Dis. Sci 51: 394-404.
50. Wallace JL, MacNaughton WK, Morris GP, Beck PL (1989) Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 96: 29-36.
51. Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206-209.
52. Lowenthal JW, Corthesy P, Tougne C, Lees R, MacDonald HR, et al. (1985) High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J Immunol 135: 3988-3994.
53. Gasson MJ (1983) Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. J Bacteriol 154: 1-9.
54. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor, N.Y.